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THE RELATIONSHIP BETWEEN HYPERSENSITIVITY AND
IMMUNITY TO VACCINIA*
G. DOUGLAS BALDRIDGE, M.D. AND ALBERT M. KLIGMAN, M.D., Ph.D.
The role that hypersensitivity plays in the phenomenon of immunity to in-
fectious agents is controversial. This question has been under investigation
since the time that Koch demonstrated that the reinoculation of tubercie bacilli
into guinea pigs brought forth responses quite different from the original in-
oculation, ("Koch's phenomenon") (1). The ulcer which results from the original
subcutaneous inoculation heals slowly and is associated with a dissemination
of the organisms throughout the body. The lesion produced in the reinoculated
animal, which by this time has become sensitive to tuberculin, heals quickly.
Moreover, the spread of organisms through the body is limited.
The issue relates to the interpretation of this "phenomenon". Is the tuberculin
sensitivity the essential feature of the immunity exhibited by the reinoculated
animal? Is it the hypersensitivity which confers this immunity? One may readily
point to a number of infectious diseases in which hypersensitivity regularly ac-
companies some degree of immunity (syphilis, leprosy, animal ringworm, etc.).
The question is whether the immunity is dependent on the hypersensitivity or
whether these are only associated or parallel phenomena. According to Krause,
hypersensitive tissues may provide immunity by their capacity to react violently
to the organism, thus confining it to the area of inflammation and preventing
its dissemination. (2) Rich believes that the inflammation develops too late to
prevent the dissemination of organisms (3, 4). Tubercie bacilli have been shown
to spread more rapidly from a site inflamed by the injection of tuberculin than
from a normal site (5). Rich has shown that animals rendered highly sensitive
to tuberculin by the injection of PPD did not acquire a resistance to the tubercle
bacillus. In summary Rich states: "There has never been placed on record one
single experiment or clinical observation that demonstrated that hypersensitivity
is necessary for the development of resistance in any stage of tuberculosis or any
other infection under any condition whatsoever" (4).
No where is the confusion about the role which hypersensitivity plays in the
development of immunity better illustrated than by the various interpretations
placed on the responses resulting from vaccinia inoculation of animals and of
humans for smallpox vaccination. In general the sequence of events in animals
reinoculated with vaccinia virus parallels that seen in tuberculosis; that is, on
primary inoculation a pustular lesion develops which reaches a peak at about
5 to 6 days and then undergoes involution with healing complete in about two
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weeks. On revaccination the lesion reaches a peak between 48 and 72 hours. It
is more severe than the original inoculation and healing is more rapid, being
completed in about six days. Much of the confusion about this subject is due to
the failure on the part of many observers to define precisely their criteria of
immunity. For example, Bland regards immunity in the guinea pig, rabbit and
monkey as "no reaction to the injection of active virus at any dilution" (6).
Broom considers that in humans the length of the interval between the inocula-
tion and the development of the peak of reaction is the essential criterion for
immunity (7). Still other workers have disregarded the skin reaction entirely
and rely on the demonstration of circulating neutralizing antibodies as evidence
of the immune state. In the present report we have arbitrarily assumed that im-
munity is demonstrated by the rapidity of healing of the experimental lesion.
This may not hold for other diseases. In vaccinia, however, it may be assumed
that healing cannot occur until the virus can no longer proliferate freely and
is finally eliminated. The healing time thus crudely measures the forces which
prevent multiplication of the virus.
The particular purpose of this study was to determine if sensitization per se
is an essential component of immunity.
METHODS AND MATERIALS
White guinea pigs weighing about 700 grams were used throughout. Areas to be used for
inoculation or skin testing were prepared 48 hours beforehand by plucking the hair. The
active virus material was pooled from several passages in the chick embryo and all virus
that was used in these experiments was taken from this original pooi. The virus was of a
potency of about 108 infectious units per ml. when titered by inoculation on the chorio-
allantoic membrane of the chick embryo. The antigen used for skin testing was obtained by
exposure of the full strength active virus suspension to ultra-violet radiation for 30 minutes
at a distance of 3 inches, with constant agitation during the exposure. This killed the virus
as demonstrated by the failure of the treated suspension to produce lesions on the chorio-
allantoic membrane. The animals were divided into three groups. The first group was the
uninfected controls "immunized" in the manner described below (Group I). The second
group was the infected controls. These animals were inoculated subcutaneously on both
sides with 0.1 ml. of the full strength live vaccinia virus suspension twenty-one days before
the main experiment was begun. The infection was allowed to run its course. The third
group, or the infected desensitized group was prepared in the same way as the infected
controls. In addition, on the twenty-third day after the original inoculation, when healing
had been complete for about 8 days, the desensitization program was begun. This involved
the daily subcutaneous inoculation of .2 ml. of full strength killed vaccinia virus suspension
up to the thirty-eighth day. Thereafter, the amount was increased to 0.5 ml. daily. An
exactly similar course of killed virus injections was given to the uninfected controls (Group
I). This was done both to see if sensitization could be established by the daily inoculation
of a large quantity of killed virus as well as to determine its "immunization" value in pro-
tecting animals which had never been infected. The infected control group (Group 2) was
not desensitized. The animals in each group were skin tested with 0.1 ml. killed vaccinia
antigen given intracutaneously on the 21st, 35th, 42nd, and 49th days after the original
inoculation of live virus. On the 51st day after the original inoculation of live vaccinia
virus, the previously infected animals were reinoculated with .1 ml. of live vaccinia virus
intracutaneously, and the animals not previously infected (Group I) were similarly in-
oculated for the first time.
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TABLE I
Results of skin tests on previously prepared guinea pigs using killed vaccinia antigen
(Desensitization begun on 23rd day)
GROUP METROD OF PREPARATION NUMBER OFANIMALS
DAYS AFTER INOCULATION
21 35 42 49
1
2
3
Uninfected, "immunized"
controlst
Infected controls
Infected and desensitized
10
5
9
0*
1.0
0.8
0
0.8
0.7
0
0.8
0.2
0.7
0.1
* Each figure represents the average diameter of the lesions in that group expressed in
centimeters.
t Treated after the 23rd day in the same manner as the infected, desensitized group
(group 3).
Average
Diameter 5mm
Skin Teat
lam — —
21 days 35 days 42 days 49 days
_Uninfeeted controls. (group )
_______________Inrected Controls (group 2)
— — ...........Jnfected and d.a.neittzed (grp 3)
Fie. I. Graphic representation of changes in hypersensitivity in previously prepared
guinea pigs.
RESULTS
The results of skin testing during the desensitization program are shown on
Table I. It will be noted that no positive reactions were elicited in the control
group given a course of killed antigen. In short these animals did not become
sensitized (Group I). There was a gradual fall in skin sensitivity after the 21st
208 THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
day in the Group 2 animals. This was slight and in the direction anticipated
with the passage of time. It should be pointed out that there was often a fairly
marked variation in the skin test responses among the animals of the same
TABLE II
Results of inoculation of live vaccinia on 51st day after preparation of guinea pigs
GROUP METHOD OF PREPARATION
NUMRER
OF
ANIMALS
PEAK
OF
REACTION
TIME TO
HEAL—
INC
REACTION
24 HOURS
REACTION
48 HOURS
1
2
3
Uninfected controls
Infected controls
Infected and desensi-
tized
10
5
9
l,rs.
144*
48
72
days
16
8
9
0
0.5 cm. papule
0.5 cm. papule
0.5 cm. papule
0.9 cm. necrotic
papule
0.8 cm. necrotic
papule
* Each figure represents the average for that group.
Necrotic
Papule
Papule
Erytheina
KET: Uninfected controls (group 1)
__________________
Infected controls (group 2)
— .............Infected and desensitized (group 3)
Fic. II. Graphic representation of course of reaction following the injection of active
vaccinia virus into previously prepared guinea pigs.
group and even in the same animal on repeated testing. In the infected and
desensitized group (Group 3), however, there was a marked loss of hyper-
sensitivity to the infectious agent. This is graphically shown in Figure I. Two
of the animals did not become completely desensitized despite the enormous
amount of dead antigen injected. We have considered that the results of skin
\
DAYS 0 1 2 3 4 5 6 7 g 10 11 12 13 14 25 16
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testing guinea pigs are very erratic and that the measurements given have
only a general significance in showing trends. Table II records the result follow-
ing the inoculation of live vaccinia on the 51st day, following the completion of
the desensitization program. In the uninfected "immunized" controls (Group
I) the peak of the reaction was reached at 144 hours and the healing time was
16 days. The reaction was similar to that observed in normal untreated animals
inoculated for the first time. In short, no immunity was induced by a course of
killed virus injections. In the infected but not desensitized controls (Group
2), the peak of the reaction was reached at 48 hours and the healing time was
much shortened. This indicated immunity as was expected. The lesion was
much more severe than that of the uninfected controls. In the infected and
desensitized group (Group 3), the reaction was similar in every way to that in
the infected controls, although there was an absence of cutaneous hypersensi-
tivity with dead virus.
DISCUSSION
The results seem to indicate that cutaneous hypersensitivity and immunity
may be dissociated experimentally; that is, one can eliminate the hypersensi-
tivity of the skin and yet not interfere with the immune process. These findings
with the vaccinia virus are in a general way in support of the thesis of Rich and
his coworkers, who have made similar observations with the tubercle bacillus.
Tuberculosis and vaccinia, however, are not comparable diseases.
Vaccination of humans against smallpox is a time-honored procedure; yet,
the interpretation of the responses of humans to such vaccination is often con-
fused. It is important that the cutaneous reactions (or lack of reaction) obtained
by inoculating vaccinia virus into previously vaccinated individuals be soundly
evaluated. The findings of the present study bear directly on this problem.
The issues to be resolved are: (1) What is the meaning of a "no take" in a
human known to have been successfully vaccinated in the past. (An unofficial
survey in our own hospital elicited the response from many physicians that
"no take" indicated a solid immunity); (2) If a reaction does occur, does this
mean that the level of immunity will be "boosted". In other words, does a re-
action increase the degree of immunity?
Returning to the first question, one may note that the experimental data
furnishes a decisive answer. Some degree of inflammatory cutaneous reaction
always occurred when vaccinia virus, live or dead, was injected into previously
infected animals. It is evident that the complete lack of a reaction ("no take")
could occur only if the virus failed to be injected below the stratum corneum.
Previously infected animals acquire a sensitivity to vaccinia antigen in exactly
the same manner as tuberculous animals develop a sensitivity to the tubercle
bacillus. Therefore, the injection of even dead virus into a previously vaccinated
animal will give a reaction which may be interpreted as a positive skin test.
Such a reaction is simply an indication of previous infection. In previously vac-
cinated humans, the "no take" reaction is certainly not an indication of im-
munity but is probably an indication of improper technic; that is, the virus
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was not actually inoculated below the stratum corneum. Thus, the "no take"
reaction has no significance whatsoever in terms of indicating immunity. When
a "no take" is obtained, the vaccination obviously must be done over.
On the other hand, coming back to the second question, how are positive
reactions in previously vaccinated humans to be interpreted? It is at once clear
that the mere elicitation of a positive reaction does not insure that the level of
immunity will be boosted. If the virus is dead, for instance, the reaction will
simply be a positive skin test which probably does not significantly raise the
level of immunity although it does indicate that the individual has previously
been infected. Presumably live virus must be inoculated to raise the existing
level of immunity. The question then arises as to how one differentiates a positive
skin test reaction (dead virus) from a truly immunizing reaction (live virus).
The experimental data furnishes a reasonably satisfactory answer. The course
of the cutaneous response to the injection of live virus differs from that follow-
ing the injection of dead virus. Initially, within the first 48—72 hours the re-
actions are roughly the same. Thereafter, the skin test reaction with dead virus
wanes, whereas the true immunizing reaction continues to become more in-
flammatory. The immunizing reaction has a later peak which incidentally,
tends to be more severe. The skin response to the immunizing action of live
virus requires at least twice as long to return to normal as the positive skin
test to dead virus. The distinction thus essentially rests on a time sequence.
The same conclusions have emerged from Beneson's work on human beings
(8). Hooker's earlier work in 1929 can now be more accurately reinterpreted
(9). This latter worker showed that there was a negative skin test reaction to
killed virus in those who would develop a primary take (non-immune reaction)
following the inoculation of living virus. Correlatively, a positive skin test
could be elicted in those who would develop the immune reaction following
inoculation of living virus. Hooker believed that a positive skin test was thus
a sign of immunity. One must point out, however, that a positive skin reaction
is a test of hypersensitivity and not of immunity per se. It is true that hyper-
sensitivity is often associated with immunity and is, at any rate, a sign of past
infection. The prior infection undoubtedly establishes some degree of lasting
immunity and it is only in the sense that a positive skin test indicates past in-
fection that one can regard it as a reflection of the immune state. Regan has
recently described in humans an immediate white papule which appeared in
3—10 minutes following a successful inoculation (10). We were unable to observe
this type of reaction in guinea pigs.
CONCLUSIONS
1. The desensitization of guinea pigs previously infected with vaccinia virus
did not result in a loss of immunity.
2. Previously infected animals always exhibited a cutaneous response whether
inoculated with living or dead virus.
3. The responses of humans to reinoculation with vaccinia virus are dis-
cussed with relation to their influence on the immune state.
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DISCUSSION
DR. BALDRIDGE, Philadelphia: If one looks upon allergy as any specific altera-
ation in the capacity to react, then immunity becomes a special case of allergy
and the distinction between the two phenomena becomes less important. There-
fore, I agree that the term "specific hypersensitivity" in a presentation of this
sort is preferable to the use of the designation "allergy".
